US Appeals Court Backs Dismissal Of Bystolic ‘Pay-For-Delay’ Case

The US Court of Appeals for the Second Circuit afirmed a US district court decision to dismiss purchaser and payer claims linked to so-called “pay-for-delay” agreements with generics firms over nebivolol rivals to Bystolic.

Appeal_Gavel
The US Court of Appeals for the Second Circuit backed the district court’s dismissal. • Source: Shutterstock

More from Generics

More from Biosimilars & Generics